Parschauer Karah Herdman
SEC CIK 1677455 · EDGAR
BoughtSold
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-04 15:15 | 2026-08-03 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $24.92 | -1,900 | 92.6K | -2% | -$47.3K |
| T | 2026-06-15 18:46 | 2026-06-15 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $24.62 | -1,899 | 94.5K | -2% | -$46.8K |
| D | 2026-04-20 17:15 | 2026-04-16 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +28.9K | 95.7K | +43% | $0 |
| M | 2026-03-10 | 2026-03-06+ | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $21.87 | -9,526 | 70.3K | -12% | -$208.3K |
| 2026-03-03 | 2026-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +11.1K | 84.4K | +15% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $22.80 | -8,135 | 76.3K | -10% | -$185.5K | |
| 2026-02-19 | 2026-02-17 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +45.6K | 77.7K | +142% | $0 | |
| 2025-09-12 | 2025-09-12 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $31.17 | -2,450 | 73.3K | -3% | -$76.4K | |
| 2025-03-14 | 2025-03-12 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | S - Sale | $12.99 | -12.9K | 32.2K | -29% | -$167.4K | |
| D | 2025-03-11 | 2025-03-07 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +7,364 | 45.1K | +20% | $0 |
| 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $42.10 | -12.8K | 75.3K | -15% | -$540.8K | |
| 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +18.4K | 88.1K | +26% | $0 | |
| DM | 2025-03-03 | 2025-02-27 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $42.88 | -2,990 | 55.0K | -5% | -$128.2K |
| D | 2025-03-03 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +14.5K | 69.7K | +26% | $0 |
| T | 2024-06-12 | 2024-06-12 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.00 | -9,806 | 58.0K | -14% | -$441.3K |
| DM | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +18.8K | 69.8K | +37% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $53.76 | -3,756 | 67.3K | -5% | -$201.9K |
| D | 2024-02-09 | 2024-02-07 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +6,464 | 37.7K | +21% | $0 |
| 2024-02-02 | 2024-01-30 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | S - Sale | $13.14 | -11.9K | 31.2K | -28% | -$156.8K | |
| 2023-05-05 | 2023-05-04 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.00 | -4,378 | 52.0K | -8% | -$197.0K | |
| DM | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +24.7K | 37.1K | +198% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.25 | -3,161 | 56.1K | -5% | -$143.0K |
| D | 2023-01-31 | 2023-01-27 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +8,293 | 43.2K | +24% | $0 |
| 2022-03-08 | 2022-03-07 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $62.95 | -5,140 | 34.4K | -13% | -$323.6K | |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +14.0K | 39.6K | +55% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, CLO | S - Sale | $66.62 | -2,886 | 25.5K | -10% | -$192.3K |
| D | 2022-01-26 | 2022-01-24 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Dir | A - Grant | $0.00 | +15.6K | 34.9K | +81% | $0 |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, GC | S - Sale | $81.14 | -310 | 28.4K | -1% | -$25.2K | |
| D | 2021-09-09 | 2021-09-08 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, GC | S - Sale+OE | $100.65 | -7,336 | 28.7K | -20% | -$738.4K |
| D | 2021-09-09 | 2021-09-08 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | EVP, GC | M - OptEx | $54.50 | +7,336 | 36.0K | +26% | +$399.8K |
Purchase Sale Sale after option exercise All abbreviations